Tuberculosis is an extremely serious problem of global public health. Its incidence is
worsened by the presence of multidrug-resistant (MDR) strains of Mycobacterium …

Background With the introduction of new anti-tuberculosis drugs, all-oral regimens with
shorter treatment durations for multidrug-resistant tuberculosis have been anticipated. We …

Tuberculosis (TB) is a significant global health threat, and cases of infection with non-
tuberculous mycobacteria (NTM) causing lung disease (NTM-LD) are rising. Bacteriophages …

Background Tuberculosis (TB), human immunodeficiency virus (HIV), and hepatitis C virus
(HCV) share a global presence and propensity to disproportionately affect marginalized …

Linezolid is a drug with proven human antitubercular activity whose use is limited to highly
drug-resistant patients because of its toxicity. This toxicity is related to its mechanism of …

Genetically antimicrobial resistance in Mycobacterium tuberculosis is currently one of the
most important aspects of tuberculosis, considering that there are emerging resistant strains …

Antitubercular drugs are associated with several adverse drug reactions (ADRs). Some of
these ADRs are life-threatening and require immediate attention and hospital admission …

Highly drug-resistant strains are not uncommon among the Mycobacterium genus, with
patients requiring lengthy antibiotic treatment regimens with multiple drugs and harmful side …

The worldwide incidence of multi-drug-resistant tuberculosis (MDR-TB) is rapidly increasing,
and it has emerged as a pressing public health issue in Iran. Nevertheless, there is a …

Understanding reperfusion damage, raising knowledge of its underlying processes, and
creating measures to lessen its negative consequences have all seen significant progress …